{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "a-synuclein",
        "Protein_Change": {
          "ref": "A30",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "a-synuclein A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson's disease (PD) is caused by a mutation in the a-synuclein gene. The A30P and A53T mutations both result in a reduction of a-synuclein levels in the brain.",
          "judgment": "Yes",
          "reasoning": "The paper defines the disease mechanism as a reduction in a-synuclein levels caused by mutations in the gene."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We measured the levels of a-synuclein in cell lines overexpressing wild type or mutant a-synuclein. The results were validated by quantitative real time RT-PCR.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (measuring protein levels) is applicable to the disease mechanism (reduced protein levels)."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "We used cell lines generated from different initial transfections to minimize variability. As a positive control for differences in gene expression, we also measured the levels of a-synuclein in clones overexpressing wild type a-synuclein.",
          "judgment": "Yes",
          "reasoning": "The paper uses variant controls (cell lines overexpressing wild type a-synuclein) to validate the assay.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "The results from the microarray experiment were confirmed for 11 out of 17 genes (64.7%). However, we were unable to confirm the results for six genes.",
          "judgment": "Yes",
          "reasoning": "The paper provides statistical analyses that can be used to calculate OddsPath.",
          "next_step_or_outcome": "Calculate OddsPath"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence strength for the A30P variant is PS3_supporting because the paper provides sufficient statistical analyses that can be used to calculate OddsPath."
    }
  ]
}